Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months.
Oliver B; Fernández O; Orpez T; Alvarenga MP; Pinto-Medel MJ; Guerrero M; León A; López-Madrona JC; Maldonado-Sánchez R; García-León JA; Luque G; Fernández V; Leyva L; Multiple Sclerosis (Houndmills, Basingstoke, England), 2011, vol. 17, issue 3, p 368, ISSN 14770970. ISBN 14770970.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef